In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “V ...

It's all about finding a look that highlights your beauty. These expert-approved hairstyles for women over 40 will do just that. No matter what your goal is, we have a whole slew of hair trends ...

Whether you're planning to cycle to work or go on some leisurely weekend rides, the best women's hybrid bikes are designed to do almost anything you want them to. They offer simplicity ...

Here’s how it works. Whether you're looking to start a new fitness routine or monitor your sleep, the best smartwatches for women can help you keep track of your goals. I've been testing the ...

Hair loss in women is a natural part of the aging process, with most women experiencing hair loss after menopause. In fact, more than half of women ages 50 and older will experience some degree of ...

It’s also worth remembering that Addyi is a failed antidepressant and Vyleesi was originally tested as a sunless tanning agent—arousal was a side effect. Both drugs eventually came out of efforts to ...

A drug for low libido, or 'acquired, generalised hypoactive sexual desire disorder' (HSDD) in premenopausal women, Addyi was approved in August amid considerable controversy, with claims that the ...

Former President Joe Biden posted on X Saturday to celebrate International Women's Day, and many Americans called out his administration's record of enabling transgender athletes to compete in ...

Despite national conversations about a lack of women in IT, women remain largely underrepresented in technology roles, according to a study by the National Science Foundation. And the pipeline ...